Found: 28
Select item for more details and to access through your institution.
Pathogen reduction with methylene blue does not have an impact on the clinical effectiveness of COVID‐19 convalescent plasma.
- Published in:
- Vox Sanguinis, 2023, v. 118, n. 4, p. 296, doi. 10.1111/vox.13406
- By:
- Publication type:
- Article
AL Amyloidosis and Multiple Myeloma: A Complex Scenario in Which Cardiac Involvement Remains the Key Prognostic Factor.
- Published in:
- Life (2075-1729), 2023, v. 13, n. 7, p. 1518, doi. 10.3390/life13071518
- By:
- Publication type:
- Article
Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19: A Meta-analysis.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 1, p. e2147331, doi. 10.1001/jamanetworkopen.2021.47331
- By:
- Publication type:
- Article
Biosimilar and interchangeable: Inseparable scientific concepts?
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 11, p. 2460, doi. 10.1111/bcp.14089
- By:
- Publication type:
- Article
Monoclonal Gammopathies of Clinical Significance: A Critical Appraisal.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5247, doi. 10.3390/cancers14215247
- By:
- Publication type:
- Article
Complex measurements may be required to establish the prognostic impact of immunophenotypic markers in AML.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Complex Measurements May Be Required to Establish the Prognostic Impact of Immunophenotypic Markers in AML.
- Published in:
- American Journal of Clinical Pathology, 2015, v. 144, n. 3, p. 484, doi. 10.1309/AJCPRL6XSVFMLH9V
- By:
- Publication type:
- Article
Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host disease.
- Published in:
- Croatian Medical Journal, 2016, v. 57, n. 3, p. 247, doi. 10.3325/cmj.2016.57.247
- By:
- Publication type:
- Article
Reduced Calcium Signaling Is Associated With Severe Graft-Versus-Host Disease: Results From Preclinical Models and From a Prospective EBMT Study.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.01983
- By:
- Publication type:
- Article
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 4, p. 690, doi. 10.1093/cid/ciab988
- By:
- Publication type:
- Article
Reply to Lewis et al.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Serum Galactomannan–Based Early Detection of Invasive Aspergillosis in Hematology Patients Receiving Effective Antimold Prophylaxis.
- Published in:
- Clinical Infectious Diseases, 2014, v. 59, n. 12, p. 1696, doi. 10.1093/cid/ciu673
- By:
- Publication type:
- Article
Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
- Published in:
- 2021
- By:
- Publication type:
- Letter
SARS-CoV-2 membrane protein-specific antibodies from critically ill SARS-CoV-2–infected individuals interact with Fc receptor–expressing cells but do not neutralize the virus.
- Published in:
- Journal of Leukocyte Biology, 2024, v. 115, n. 5, p. 985, doi. 10.1093/jleuko/qiae017
- By:
- Publication type:
- Article
Treatment for First Cytomegalovirus Infection Post–Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 3, p. 562, doi. 10.1093/cid/ciad709
- By:
- Publication type:
- Article
European data on stem cell mobilization with plerixafor in patients with nonhematologic diseases: an analysis of the European consortium of stem cell mobilization.
- Published in:
- Transfusion, 2012, v. 52, n. 11, p. 2395, doi. 10.1111/j.1537-2995.2012.03603.x
- By:
- Publication type:
- Article
Cell Count Differentials by Cytomorphology and Next-Generation Flow Cytometry in Bone Marrow Aspirate: An Evidence-Based Approach.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 6, p. 1071, doi. 10.3390/diagnostics13061071
- By:
- Publication type:
- Article
Outcomes of alemtuzumab-based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 2006, v. 135, n. 2, p. 201, doi. 10.1111/j.1365-2141.2006.06272.x
- By:
- Publication type:
- Article
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA).
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.992137
- By:
- Publication type:
- Article
Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope.
- Published in:
- Mycoses, 2023, v. 66, n. 1, p. 35, doi. 10.1111/myc.13524
- By:
- Publication type:
- Article
Invasive fungal infections in AML/ MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?
- Published in:
- Mycoses, 2016, v. 59, n. 8, p. 516, doi. 10.1111/myc.12500
- By:
- Publication type:
- Article
Standards of CARE: what is considered 'best practice' for the management of invasive fungal infections? A haematologist's and a mycologist's perspective.
- Published in:
- 2019
- By:
- Publication type:
- journal article
European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2018, v. 73, n. 12, p. 3221, doi. 10.1093/jac/dky286
- By:
- Publication type:
- Article
Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The current management landscape: aspergillosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Secondary effects after belantamab treatment: A new anti‐B‐cell maturation antigen monoclonal antibody for multiple myeloma.
- Published in:
- EJHaem, 2021, v. 2, n. 3, p. 646, doi. 10.1002/jha2.205
- By:
- Publication type:
- Article